scholarly journals Intravascular disseminated coagulopathy as a debut of metastatic prostate cancer: A case report

2017 ◽  
Vol 7 (1) ◽  
pp. 52 ◽  
Author(s):  
Paula Espinosa Olarte ◽  
Nerea Inés Muñoz Unceta ◽  
Ray Manneh Kopp ◽  
Jesús González Olmedo ◽  
Daniel Castellano Gauna ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Case Report ◽  
Hormonal Therapy ◽  
Metastatic Prostate Cancer ◽  
Chemohormonal Therapy ◽  
Life Threatening ◽  
The Way

Hormonal therapy has been the treatment axis of metastatic prostate cancer since 1940. Identifying rare forms of debut is important in order to initiate the best treatment as soon as possible. Intravascular disseminated coagulopathy (DIC) related to prostate cancer is mostly presented as chronic forms. Acute forms can also be the way of presentation, recognizing them is crucial due to its life threatening nature. Here, we present a case of debut of metastatic prostate cancer as an acute DIC. Reporting this case is important because of the unfrequently presentation and to consider combined chemohormonal therapy since the diagnosis.

scholarly journals Large Bowel Obstruction Caused by Metastatic Prostate Cancer: A Case Report

2021 ◽  
Author(s):  
Mohamad Khaled Almujarkesh ◽  
Mahmoud Ismayl ◽  
Ahmad Ismayl ◽  
Muhammad Alsayid ◽  
Muhammed Rodwan Hiba
Keyword(s):  
Prostate Cancer ◽  
Case Report ◽  
Lymph Nodes ◽  
Bowel Obstruction ◽  
Hormonal Therapy ◽  
Large Bowel ◽  
Metastatic Prostate Cancer ◽  
Large Bowel Obstruction ◽  
Metastatic Carcinoma ◽  
Rectal Mass

AbstractBowel obstruction is a frequently encountered condition worldwide that causes numerous admissions to hospitals. Metastatic carcinoma has been identified as one of the infrequently encountered causes of bowel obstruction. Prostate cancer typically metastasizes to lymph nodes, bone, lungs, liver, and brain. In this article, we reported the case of a 75-year-old man who presented with bowel obstruction due to narrowing and stricture of the rectum. Primary rectal mass was initially diagnosed, but upon further investigation, it was found that the mass resembled prostate tissue. The bowel obstruction was managed surgically with a colostomy. The patient was later referred to oncology for chemotherapy and hormonal therapy.

scholarly journals Hepatic failure induced by cyproterone acetate: A case report and literature review

2014 ◽  
Vol 8 (5-6) ◽  
pp. 458 ◽  
Author(s):  
Jae Heon Kim ◽  
Byung Wook Yoo ◽  
Won Jae Yang
Keyword(s):  
Prostate Cancer ◽  
Critical Care ◽  
Case Report ◽  
Literature Review ◽  
Hepatic Failure ◽  
Cyproterone Acetate ◽  
Metastatic Prostate Cancer ◽  
Gross Hematuria

Cyproterone acetate (CPA) is an anti-androgenic drug that has been used to manage prostate cancer. The drug is well-tolerated, but has hepatotoxic effects. Hepatic failure induced by CPA is rare and urologists tend to overlook its severity. We report a patient with metastatic prostate cancer who developed CPA-induced hepatic failure that manifested as bilirubinuria, which was initially misinterpreted as gross hematuria. The patient died despite receiving critical care. The aim of this study is to sound the alarm about CPA-induced hepatic failure.

scholarly journals Eruptive nodules of the head and neck: a case report of metastatic prostate cancer

2014 ◽  
Vol 20 (2) ◽  
Author(s):  
Gabrielle Brown ◽  
Drew Kurtzman ◽  
Fangru Lian ◽  
James Sligh
Keyword(s):  
Prostate Cancer ◽  
Case Report ◽  
Head And Neck ◽  
Metastatic Prostate Cancer

Population Based Study of Hormonal Therapy and Survival in Men With Metastatic Prostate Cancer

2007 ◽  
Vol 177 (2) ◽  
pp. 535-539 ◽  
Author(s):  
Grace Lu-Yao ◽  
Dirk F. Moore ◽  
John U. Oleynick ◽  
Robert S. DiPaola ◽  
Siu-Long Yao
Keyword(s):  
Prostate Cancer ◽  
Hormonal Therapy ◽  
Metastatic Prostate Cancer ◽  
Population Based ◽  
Population Based Study
Sign in / Sign up

Export Citation Format

Share Document